First Trust Advisors LP Ultragenyx Pharmaceutical Inc. Transaction History

First Trust Advisors LP

  • $108 Billion
  • Q4 2024

A detailed history of First Trust Advisors LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 544,202 shares of RARE stock, worth $24.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
544,202
Previous 17,022 3097.05%
Holding current value
$24.2 Million
Previous $945,000 2322.65%
% of portfolio
0.02%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$42.07 - $57.72 $22.2 Million - $30.4 Million
527,180 Added 3097.05%
544,202 $22.9 Million
Q3 2024

Nov 13, 2024
SELL
$40.21 - $59.36 $10.6 Million - $15.7 Million
-264,071 Reduced 93.94%
17,022 $945,000
Q2 2024

Aug 13, 2024
SELL
$37.42 - $51.61 $3.26 Million - $4.5 Million
-87,126 Reduced 23.66%
281,093 $11.6 Million
Q1 2024

May 13, 2024
SELL
$43.02 - $53.69 $34.2 Million - $42.7 Million
-794,858 Reduced 68.34%
368,219 $17.2 Million
Q4 2023

Feb 13, 2024
SELL
$31.73 - $49.19 $1.23 Million - $1.9 Million
-38,611 Reduced 3.21%
1,163,077 $55.6 Million
Q3 2023

Nov 13, 2023
BUY
$34.92 - $46.66 $1.64 Million - $2.19 Million
46,852 Added 4.06%
1,201,688 $42.8 Million
Q2 2023

Aug 14, 2023
SELL
$37.35 - $52.15 $2.16 Million - $3.01 Million
-57,780 Reduced 4.76%
1,154,836 $53.3 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $2.54 Million - $3.34 Million
68,644 Added 6.0%
1,212,616 $48.6 Million
Q4 2022

Feb 09, 2023
BUY
$33.72 - $46.33 $15.5 Million - $21.3 Million
459,628 Added 67.16%
1,143,972 $53 Million
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $4.74 Million - $7.85 Million
118,699 Added 20.98%
684,344 $28.3 Million
Q2 2022

Aug 12, 2022
SELL
$45.8 - $85.4 $7.24 Million - $13.5 Million
-158,113 Reduced 21.85%
565,645 $33.7 Million
Q1 2022

May 13, 2022
SELL
$62.2 - $84.4 $1.17 Million - $1.59 Million
-18,883 Reduced 2.54%
723,758 $52.6 Million
Q4 2021

Feb 08, 2022
BUY
$73.71 - $87.86 $1.88 Million - $2.24 Million
25,533 Added 3.56%
742,641 $62.4 Million
Q3 2021

Nov 15, 2021
BUY
$77.92 - $102.4 $9.6 Million - $12.6 Million
123,165 Added 20.74%
717,108 $64.7 Million
Q2 2021

Aug 16, 2021
BUY
$92.19 - $115.71 $3.26 Million - $4.09 Million
35,364 Added 6.33%
593,943 $56.6 Million
Q1 2021

May 14, 2021
SELL
$106.9 - $167.73 $21.9 Million - $34.4 Million
-205,226 Reduced 26.87%
558,579 $63.6 Million
Q4 2020

Feb 02, 2021
SELL
$84.4 - $177.39 $14.7 Million - $30.8 Million
-173,709 Reduced 18.53%
763,805 $106 Million
Q3 2020

Nov 05, 2020
SELL
$72.98 - $90.0 $17.1 Million - $21.1 Million
-234,195 Reduced 19.99%
937,514 $77.1 Million
Q2 2020

Jul 22, 2020
BUY
$46.91 - $78.22 $10.6 Million - $17.6 Million
225,205 Added 23.79%
1,171,709 $91.7 Million
Q1 2020

May 06, 2020
SELL
$33.8 - $62.9 $8.16 Million - $15.2 Million
-241,459 Reduced 20.33%
946,504 $42.1 Million
Q4 2019

Feb 03, 2020
BUY
$36.08 - $45.83 $6.81 Million - $8.65 Million
188,797 Added 18.9%
1,187,963 $50.7 Million
Q3 2019

Nov 04, 2019
SELL
$42.5 - $63.11 $21.9 Million - $32.6 Million
-516,029 Reduced 34.06%
999,166 $42.7 Million
Q2 2019

Jul 30, 2019
SELL
$54.93 - $74.36 $18.9 Million - $25.6 Million
-343,857 Reduced 18.5%
1,515,195 $96.2 Million
Q1 2019

May 09, 2019
BUY
$39.87 - $69.36 $15.4 Million - $26.9 Million
387,118 Added 26.3%
1,859,052 $129 Million
Q4 2018

Feb 07, 2019
BUY
$38.89 - $77.3 $8.11 Million - $16.1 Million
208,468 Added 16.5%
1,471,934 $64 Million
Q3 2018

Oct 25, 2018
BUY
$71.81 - $90.15 $20.5 Million - $25.8 Million
285,961 Added 29.25%
1,263,466 $96.5 Million
Q2 2018

Aug 02, 2018
BUY
$48.54 - $85.31 $811,249 - $1.43 Million
16,713 Added 1.74%
977,505 $75.1 Million
Q1 2018

Apr 23, 2018
BUY
$44.33 - $58.52 $7.76 Million - $10.2 Million
175,098 Added 22.29%
960,792 $49 Million
Q4 2017

Feb 08, 2018
BUY
$43.54 - $57.32 $11.3 Million - $14.9 Million
259,816 Added 49.41%
785,694 $36.4 Million
Q3 2017

Oct 24, 2017
BUY
$49.79 - $66.32 $26.2 Million - $34.9 Million
525,878
525,878 $28 Million

Others Institutions Holding RARE

# of Institutions
344
Shares Held
86.6M
Call Options Held
675K
Put Options Held
846K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.12B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email